Glycoxidation and oxidative stress in Parkinson disease and diffuse Lewy body disease

Brain Research

Volumn 737, Issue 1-2, 1996, Pages 195-200

  Castellani, R ^a   Smith, M A ^b   Richey, P L ^b   Perry, G ^b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Advanced glycation end product; Diffuse Lewy body disease; Immunocytochemistry; Oxidative stress; Parkinson's disease

Indexed keywords

HEME OXYGENASE; PENTOSIDINE; PYRRALINE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CASE REPORT; CONTROLLED STUDY; ELECTRON MICROSCOPY; GLYCATION; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; LEWY BODY; NEOCORTEX; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; SUBSTANTIA NIGRA;

EID: 0030597071     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-8993(96)00729-9     Document Type: Article

References (31)

1. [1] Baynes, J.W., Role of oxidative stress in development of complications in diabetes, Diabetes, 40 (1991) 405-412.
2. [2] Beckman, J.S., Carson, M., Smith, CD. and Koppenol, W.H., ALS, SOD and peroxynitrite, Nature, 364 (1993) 584.
3. [3] Castellani, R., Smith, M.A., Richey, P.L., Kalaria, R., Gambetti, P. and Perry, G., Evidence for oxidative stress in Pick disease and corticobasal degeneration, Brain Res., 696 (1995) 268-271.
4. [4] Cruse, I. and Maines, D., Evidence suggesting that the two forms of heme oxygenase are products of different genes, J. Biol. Chem., 263 (1988) 3348-3353.
5. [5] Dickson, D.W., Schmidt, M.L., Lee, V.M., Zhao, M.L., Yen, S.H. and Trojanowski, J.Q., Immunreactivity profile of CA2/3 neurites in diffuse Lewy body disease, Acta Neuropath., 87 (1994) 269-276.
6. [6] Galloway, P.G., Grundke-Iqbal, I., Iqhal, K. and Perry, G., Lewy bodies contain epitopes both shared and distinct from Alzheimer neurofibrillary tangles, J. Neuropathol. Exp. Neurol. 47 (1988) 654-663.
7. [7] Hunt, J.V., Dean, R.T. and Wolff, S.P., Hydroxyl radical production and autoxidative glycosylation. Glucose autoxidation as the cause of protein damage in the experimental glycation model of diabetes mellitus and ageing, Biochem. J. 256 (1988) 205-212.
8. [8] Keyse, S.M. and Tyrrell, R.M., Heme oxygenase is the major 32-kDa stress protein induced in human skin fibroblasts by UVA radiation, hydrogen peroxide, and sodium arsenite, Proc. Natl. Acad. Sci. USA, 86 (1989) 99-103.
9. [9] Maines, M.D., Heme oxygenase: function, multiplicity, regulatory mechanisms, and clinical applications, FASEB J., 2 (1988) 2557-2568.
10. [10] Maines, M.D., Trakshel, G.M. and Kutty, R.K., Characterization of two constitutive forms of rat liver microsomal heme oxygenase. Only one molecular species of the enzyme is inducible, J. Biol. Chem., 261 (1986) 411-419.
11. [11] Manetto, V., Perry, G., Tabaton, M., Mulvihill, P., Fried, V.A., Smith, H.T., Gambetti, P. and Autilio-Gambetti, L., Ubiquitin is associated with abnormal cytoplasmic filaments characteristic of neurodegenerative diseases, Proc. Natl. Acad. Sci. USA, 85 (1988) 4501-4505.
12. [12] Mecocci, P., MacGarvey, U. and Beal, M.F., Oxidative damage to mitchondrial DNA is increased in Alzheimer's disease, Ann. Neurol., 36 (1994) 747-751.
13. [13] Metuzals, J., Fishman, H.M. and Robb, I.A., The neurofilamentous network-smooth endoplasmic reticulum complex in transected giant squid axon, Biol. Bull., 189 (1995) 216-218.
14. [14] Miyata, S. and Monnier, V., Immunohistochemical detection of advanced glycation end products in diabetic tissues using monoclonal antibody to pyrraline, J. Clin. Invest., 89 (1992) 1102-1112.
15. [15] Mullarkey, C.J., Edelstein, D. and Brownlee, M., Free radical generation by early glycation products: a mechanism for accelerated atherogenesis in diabetes, Biochem. Biophys. Res. Commun., 173 (1990) 932-939.
16. [16] Olanow, C.W., A radical hypothesis for neurodegeneration, Trends Neurosci., 16 (1993) 439-444.
17. [17] Perry, G., Mulvihill, P., Manetto, V., Autilio-Gambetti, L. and Gambetti, P., Immuncytochemical properties of Alzheimer straight filaments, J. Neurosci., 7 (1987) 3736-3738.
18. [18] Premkumar, D.R.D., Smith, M.A., Richey, P.L., Petersen, R.B., Castellani, R., Kutty, R.K., Wiggert, B., Perry, G. and Kalaria, R.N., Induction of heme oxygenase-1 mRNA and protein in neocortex and cerebral vessels in Alzheimer's disease, J. Neurochem., 65 (1995) 1399-1402.
19. [19] Rotenberg, M.O. and Maines, M.D., Isolation, characterization, and expression in Escherichia coli of a cDNA encoding rat heme oxygenase-2, J. Biol. Chem., 265 (1990) 7501-7506.
20. [20] Sanchez-Ramos, J., Overvik, E. and Ames, B., A marker of oxyradical-mediated DNA damage (8-hydroxy-2′deoxyguanosine) is increased in nigro-striatum of Parkinson's disease brain, Neurodegeneration, 3 (1994) 197-204.
21. [21] Schubert, D., Behl, C., Lesley, R., Brack, A., Dargusch, R., Sagara, Y. and Kimura, H., Amyloid peptides are toxic via a common oxidative mechanism, Proc. Natl. Acad. Sci. USA. 92 (1995) 1989-1993.
22. [22] Smith, M.A., Taneda, S., Richey, P.L., Miyata, S., Van, S.-D., Stern, D., Sayre, L.M., Monnier, V.M. and Perry, G., Advanced Maillard reaction end products arc associated with Alzheimer disease pathology, Proc. Natl. Acad. Sci. USA, 91 (1994) 5710-5714.
23. [23] Smith, M.A., Kutty, R.K., Richey, P.L., Van, S.-D., Stern, D., Chader, G.J., Wiggert, B., Petersen, R.B. and Perry, G., Heme oxygenase-1 is associated with the neurofibrillary pathology of Alzheimer' disease, Am. J. Pathol., 145 (1994) 42-47.
24. [24] Smith, M.A., Sayre, L.M., Monnier, V.M. and Perry, G., Radical ageing and Alzheimer's disease, Trends Neurosci., 18 (1995) 172-176.
25. [25] Smith, M.A., Rudnicka-Nawrot, M., Richey, P.L., Praprotnik, D., Mulvihill, P., Miller, C.A., Sayre, L.M. and Perry, G., Carbonyl-related posttranslational modification of neurofilament protein in the neurofibrillary pathology of Alzheimer's disease, J. Neurochem., 64 (1995) 2660-2666.
26. [26] Smith, M.A., Richey, P.L., Kutty, R.K., Wiggert, B. and Perry, G., Ultrastructural localization of heme oxygenase-1 to the neurofibrillary pathology of Alzheimer disease, Mol. Chem. Neuropathol., 24 (1995) 227-230.
27. [27] Sternberger, L.A., Immunocytochemistry, 3rd edn., Wiley Press, New York, 1986.
28. [28] Stocker, R., Yamamoto, Y., McDonagh, A.F., Glazer, A.N. and Ames, B.N., Bilirubin is an antioxidant of possible physiological importance, Science, 235 (1987) 1043-1046.
29. [29] Tabaton, M., Whitehouse, P.J., Perry, G., Davies, P., Autilio-Gambetti, L. and Gambetti, P., Alz-5O recognizes abnormal filaments in Alzheimer's disease and progressive supranuclear palsy, Ann. Neurol., 24 (1988) 407-413.
30. [30] Trakshel, G.M. and Maines, M.D., Multiplicity of heme oxygenase isoenzymes. HO-1 and HO-2 are different molecular species in rat and rabbit. J. Biol. Chem., 264 (1989) 1323-1328.
31. [31] Verma, A., Hirsch, D.J., Glatt, C.B., Ronnett, G.V. and Snyder, S.H., Carbon monoxide: a putative neural messenger, Science, 259 (1993) 381-384.